PK/PD modeling predicts robust target engagement and low probability of grade 4 hematological toxicity at recommended phase 2 starting dose of VX-970 in combination with carboplatin (AUC=5)
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS（2016）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined